Hims vs Ozari for Weight Loss: A Side-by-Side Comparison of GLP-1 Telehealth Services

Sarah had been researching GLP-1 weight loss options for three weeks when she realized something frustrating: every telehealth company seemed to promise the same thing, but the details were buried in fine print. She'd seen Hims ads during her favorite podcast and Ozari pop up while searching for affordable semaglutide. Both offered compounded medications. Both had telehealth consultations. Both claimed transparent pricing. So what's actually different?

If you're comparing Hims and Ozari for weight loss, you're not alone. The GLP-1 telehealth space has exploded over the past two years, with dozens of companies offering compounded semaglutide and tirzepatide at prices well below branded medications like Ozempic and Mounjaro. But not all providers are created equal. The differences in pricing transparency, medication sourcing, clinical support, and overall patient experience can significantly impact your weight loss journey and your wallet.

Understanding What You're Actually Getting

Let's start with what both companies offer at their core: access to compounded GLP-1 receptor agonists through telehealth consultations. Both Hims and Ozari provide semaglutide and tirzepatide, the same active ingredients found in brand-name medications that showed 15-20% average body weight reduction in the STEP 1 and SURMOUNT-1 trials.

Compounded medications are created by specialized pharmacies when there's a shortage of FDA-approved drugs or when patients need customized dosing. They contain the same active pharmaceutical ingredients but aren't FDA-approved as finished products. This is perfectly legal and often medically necessary, but it's important to understand what you're getting.

Hims has been around since 2017, originally focusing on men's health issues like hair loss and erectile dysfunction before expanding into weight loss. They've built a recognizable brand with significant advertising spend and celebrity endorsements. Their weight loss program launched more recently, riding the wave of GLP-1 popularity that peaked in 2023-2024.

Ozari Health, by contrast, was built specifically for metabolic health and GLP-1 therapy. The company focuses exclusively on weight management and related metabolic conditions, which means their entire clinical infrastructure, educational resources, and patient support systems are designed around this single specialty.

Both companies follow a similar initial process: you complete an online health assessment, consult with a licensed healthcare provider via telehealth, and if approved, receive your medication by mail. The medications themselves are compounded at FDA-registered 503B facilities that must follow strict quality standards. However, the experience beyond these basics differs in meaningful ways.

Breaking Down the Real Cost

Pricing is where things get interesting, and frankly, where many patients get confused. Hims advertises weight loss medication starting at $199/month, though many patients report paying between $299-$399/month depending on their prescribed dose and medication type. Their pricing structure adjusts based on which medication you're prescribed and your dosage level.

Ozari takes a different approach with transparent, flat-rate pricing starting at $99/month for compounded semaglutide. This price includes the medication, shipping, supplies, and ongoing clinical support. There's no price increase as you move through dosage levels, which is particularly important because GLP-1 therapy typically involves gradual dose escalation over several months.

Here's why this matters: semaglutide therapy usually starts at 0.25mg weekly and titrates up to 2.4mg over several months. Tirzepatide starts at 2.5mg and can go up to 15mg. If your provider charges differently at each dose level, your monthly cost could double or triple as your treatment progresses. We see patients frequently surprised by this when they didn't understand the pricing structure upfront.

Beyond the monthly medication cost, consider what's included. Some telehealth companies charge separately for the initial consultation (often $49-$99), follow-up visits, or shipping. Others bundle everything into their monthly price. Hims includes the initial consultation in their membership structure, but their monthly medication pricing is where costs accumulate.

Insurance doesn't typically cover compounded medications, so you'll be paying out-of-pocket with either service. However, the total out-of-pocket difference over a six-month treatment course can be substantial. At $99/month, you'd spend $594 with Ozari over six months. At $299-$399/month with Hims, you're looking at $1,794-$2,394 for the same timeframe.

Neither company requires a long-term contract, which is good news. You can pause or cancel if you experience side effects, reach your goal weight, or simply want to try a different approach. This flexibility is essential because GLP-1 medications don't work for everyone, and individual responses vary considerably.

Clinical Support and Patient Experience

The quality of ongoing clinical support separates adequate telehealth services from excellent ones. GLP-1 medications are powerful tools, but they come with potential side effects, dosing questions, and the need for regular monitoring. You're not just buying a drug; you're entering into a treatment relationship.

Hims provides access to healthcare providers through their platform, with messaging available for questions and concerns. Their provider network spans multiple specialties since they offer services beyond weight loss. You'll communicate primarily through their app and portal, and response times for non-urgent questions typically range from a few hours to a day or two. For prescription renewals and routine matters, the system works reasonably well.

Ozari's clinical model centers on metabolic health specialists who work exclusively with GLP-1 patients. Because the entire care team focuses on weight management and metabolic conditions, they're deeply familiar with the nuanced challenges of semaglutide and tirzepatide therapy. Response times for patient questions are typically faster, and the clinical guidance tends to be more specific to GLP-1-related concerns.

In our clinical experience, patients benefit most from providers who manage GLP-1 therapy regularly and understand the subtleties of dosing adjustments, side effect management, and what constitutes normal versus concerning symptoms. A provider who prescribes these medications daily will have different insights than one who writes an occasional prescription among dozens of other health conditions.

Both platforms offer telehealth check-ins, but the frequency and depth vary. Regular monitoring is particularly important during the first few months when you're adjusting to the medication and titrating doses. Questions about nausea management, injection technique, missed doses, and when to increase your dose are incredibly common, especially early on.

Educational resources matter too. Ozari provides detailed guidance on nutrition while taking GLP-1s, exercise recommendations, managing side effects, and what to expect at each stage of treatment. Hims offers educational content as well, though it's spread across their various service lines. If you're the type of person who wants to understand your treatment deeply, the availability of specialized, detailed information makes a difference.

Medication Quality and Sourcing

When you're injecting something into your body weekly, you want confidence in its quality and safety. Both Hims and Ozari use compounded medications from FDA-registered 503B outsourcing facilities, which is the appropriate source for compounded sterile injectables. These facilities must follow Current Good Manufacturing Practices (CGMP) and undergo FDA inspection.

However, not all compounding pharmacies are identical. The best ones conduct regular sterility testing, maintain detailed batch records, and use pharmaceutical-grade active ingredients from verified suppliers. They should provide certificates of analysis showing that each batch meets specifications for identity, strength, quality, and purity.

Ozari is transparent about their pharmacy partners and quality assurance processes. They work with select 503B facilities that maintain accreditation from organizations like PCAB (Pharmacy Compounding Accreditation Board). This third-party accreditation adds another layer of quality verification beyond basic FDA registration.

Hims doesn't disclose as much detail about their specific pharmacy partners or quality control processes on their public-facing materials. This doesn't necessarily mean their quality is inferior, but transparency in pharmaceutical sourcing is generally considered a positive sign in the industry.

Storage and shipping matter for medication stability. Semaglutide and tirzepatide should be refrigerated until first use, and some formulations require cold-chain shipping to maintain potency. Both companies ship with appropriate cold packs, but it's worth confirming that your medication arrives cold and checking the specific storage requirements for your formulation.

The actual syringes, needles, and supplies included with your medication also vary. Most GLP-1 patients use insulin syringes with very fine needles (typically 31-32 gauge) to minimize injection discomfort. Ozari includes all necessary supplies with each shipment. Hims provides supplies as well, though some patients report needing to request additional needles or alcohol swabs separately.

What Women Should Know

Women make up approximately 60-70% of GLP-1 weight loss patients, and there are gender-specific considerations worth understanding. Hormonal fluctuations throughout the menstrual cycle can affect both appetite and GLP-1 side effects. Some women notice increased nausea or changes in food aversions during certain phases of their cycle.

If you're of childbearing age, pregnancy planning becomes important. The STEP trials excluded pregnant women, and current guidelines recommend discontinuing semaglutide at least two months before attempting to conceive. Tirzepatide recommendations are similar. Both Hims and Ozari should screen for pregnancy plans during your consultation, but this is something to proactively discuss with your provider.

Women also tend to experience nausea and gastrointestinal side effects slightly more frequently than men in clinical trials, though the difference isn't dramatic. Having responsive clinical support to help manage these symptoms becomes particularly valuable. We often recommend women start their injections on Friday evenings during the first few weeks, so if nausea occurs, it's less likely to interfere with work schedules.

Bone health is another consideration for women, especially those approaching or past menopause. Rapid weight loss can affect bone density, so adequate calcium, vitamin D, and protein intake become important. A provider focused on metabolic health will typically discuss these nutritional considerations as part of your care plan.

What Men Should Know

Men typically lose weight slightly faster on GLP-1 medications than women, likely due to higher baseline metabolic rates and lean muscle mass. In the STEP 1 trial, male participants lost an average of 15.4% of body weight compared to 15.1% in women over 68 weeks, though this difference wasn't statistically significant.

Testosterone levels can be affected by significant weight loss, usually in a positive direction. Many overweight men have lower testosterone related to excess adipose tissue, and weight loss often naturally improves testosterone levels. However, if you're already on testosterone replacement therapy through a service like Hims (which offers this separately), your dosing may need adjustment as you lose weight.

Men are statistically less likely to report side effects or seek help managing them, which can lead to premature discontinuation of effective therapy. Don't tough it out if you're experiencing persistent nausea, constipation, or other bothersome symptoms. These medications work best when you can tolerate them comfortably enough to stay consistent.

Cardiovascular benefits of GLP-1 medications may be particularly relevant for men, who face higher baseline cardiovascular risk than women until later in life. The SELECT trial demonstrated that semaglutide reduced major cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease. If you have a history of heart disease, hypertension, or concerning family history, this cardiovascular protection is a significant bonus beyond weight loss.

From the Ozari Care Team

We recommend choosing a GLP-1 provider based on three factors: transparent pricing that won't surprise you as doses increase, responsive clinical support from providers who specialize in metabolic health, and clear information about medication sourcing and quality. In our experience, patients who understand exactly what they're paying and have easy access to clinical guidance when questions arise stay on treatment longer and achieve better results. What we tell our patients is that the cheapest option isn't always the best value, but the most expensive isn't necessarily better either—look for the combination of affordability, quality, and support that matches your needs and communication preferences.

Key Takeaways

• Ozari offers flat-rate pricing starting at $99/month with no increases as your dose escalates, while Hims pricing typically ranges from $199-$399/month depending on medication and dosage level
• Both companies provide compounded semaglutide and tirzepatide from FDA-registered 503B facilities, but Ozari offers more transparency about pharmacy partners and quality control processes
• Ozari's care team specializes exclusively in metabolic health and GLP-1 therapy, while Hims providers manage multiple health conditions across their broader platform
• Neither service requires long-term contracts, allowing you to pause or cancel if needed, which is important given that individual responses to GLP-1 medications vary significantly
• Total six-month costs differ substantially—approximately $594 with Ozari versus $1,794-$2,394 with Hims based on typical pricing structures

Frequently Asked Questions

Is compounded semaglutide as effective as Ozempic?

Compounded semaglutide contains the same active ingredient as brand-name Ozempic and works through the same mechanism. When properly compounded by quality pharmacies, it should be bioequivalent and produce similar results. The main difference is that compounded versions aren't FDA-approved as finished products, though the active pharmaceutical ingredient itself is the same molecule that's been extensively studied. In clinical practice, we see comparable weight loss results with quality compounded semaglutide, typically 15-20% body weight reduction over 68 weeks when combined with lifestyle modifications.

Why is Ozari so much cheaper than Hims?

Ozari's lower pricing reflects their focused business model and operational choices rather than inferior medication quality. They specialize exclusively in metabolic health rather than managing multiple product lines, which creates operational efficiencies. They also maintain a flat-rate pricing structure across all dose levels, whereas Hims adjusts pricing by dose. Additionally, companies make different decisions about marketing spend, celebrity endorsements, and profit margins. Ozari's approach prioritizes accessibility and affordable pricing, while Hims invests more heavily in brand advertising and broader platform development across multiple health categories.

Can I switch from Hims to Ozari or vice versa?

Yes, you can switch between GLP-1 providers without medical complications since you'd be continuing the same medication and likely staying at the same dose level. You'll need a new consultation with your new provider, who will review your treatment history and current dose before writing a prescription. It's helpful to know exactly what dose you're currently taking and how long you've been on it. Most patients switch to find better pricing or customer service rather than for medical reasons. Just make sure to time your switch so you don't run out of medication—order from your new provider before your current supply expires.

Do I need to stay on these medications forever?

This is one of the most common questions we get, and the honest answer is that it varies by individual. Clinical trials show that most people regain weight when they stop GLP-1 medications, though not everyone regains all the weight lost. Some patients use these medications to reach their goal weight, then transition to maintenance strategies including lifestyle modifications, while others find that ongoing medication provides the best long-term results. There's no medical requirement to stay on them indefinitely, and many people successfully use them as a tool during a specific weight loss phase. The decision should be made collaboratively with your healthcare provider based on your individual response, goals, and preferences.

What happens if I experience side effects with either service?

Both Hims and Ozari should provide clinical support for managing side effects, which are common especially during the first few weeks and after dose increases. Typical side effects include nausea, constipation, diarrhea, and decreased appetite. Most are manageable with dose adjustments, timing changes, dietary modifications, or symptomatic treatment. You should be able to message your provider through the platform to describe your symptoms and get guidance. If side effects are severe or concerning, you may need to reduce your dose, pause treatment temporarily, or in rare cases, discontinue the medication entirely. The key difference is response time and provider expertise—specialized metabolic health providers often have more specific strategies for managing GLP-1 side effects because they see them constantly.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Learn more at ozarihealth.com.